Skip to content
lifestyle.celebhomes.net
Home
Sample Page
Author:
Moderna, Inc.
Dr. David Berman to Join Moderna as Chief Development Officer
January 30, 2026
Moderna Announces Strategic Collaboration with Recordati to Globally Commercialize Investigational Propionic Acidemia Therapeutic (mRNA-3927)
January 29, 2026
Moderna to Report Fourth Quarter 2025 Financial Results on Friday, February 13, 2026
January 26, 2026
Moderna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026
Moderna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine
January 5, 2026
CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Vaccine Candidate
December 20, 2025
Moderna to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 19, 2025
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s mNEXSPIKE (COVID-19 Vaccine, mRNA)
December 15, 2025
←
Previous Page
1
2
3